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Cohort profile
AbstrACt
Purpose While most research focuses on the 
association between medical characteristics and 
residual morbidity of survivors of the acute respiratory 
distress syndrome (ARDS), little is known about the 
relation between potentially modifiable intensive care 
unit (ICU) features and the course of health-related 
quality of life (HRQoL). Accordingly, the DACAPO study 
was set up to elucidate the influence of quality of 
intensive care on HRQoL and return to work (RtW) in 
survivors of ARDS. The continued follow-up of these 
former ICU patients leads to the establishment of the 
DACAPO (survivor) cohort.
Participants Sixty-one ICUs all over Germany recruited 
patients with ARDS between September 2014 and April 
2016. Inclusion criteria were: (1) age older than 18 
years and (2) ARDS diagnosis according to the ‘Berlin 
definition’. No further inclusion or exclusion criteria were 
applied. 1225 patients with ARDS could be included 
in the DACAPO ICU sample. Subsequently, the 876 
survivors at ICU discharge form the actual DACAPO 
cohort.
Findings to date The recruitment of the participants of 
the DACAPO cohort and the baseline data collection has 
been completed. The care-related data of the DACAPO 
cohort reveal a high proportion of adverse events (in 
particular, hypoglycaemia and reintubation). However, 
evidence-based supportive measures were applied 
frequently.
Future plans Three months, 6 months and 1 year after 
ICU admission a follow-up assessment is conducted. 
The instruments of the follow-up questionnaires 
comprise the domains: (A) HRQoL, (B) RtW, (C) general 
disability, (D) psychiatric symptoms and (E) social 
support. Additionally, an annual follow-up of the DACAPO 
cohort focusing on HRQoL, psychiatric symptoms and 
healthcare utilisation will be conducted. Furthermore, 
several add-on projects affecting medical issues are 
envisaged.
trial registration number NCT02637011.
IntroduCtIon   
Acute respiratory distress syndrome (ARDS) 
is a serious condition characterised by 
life-threatening damage of the lung paren-
chyma.1 The management of ARDS requires 
comprehensive intensive care unit (ICU) 
treatment including mandatory mechanical 
ventilation. The diagnostic criteria of ARDS 
according to the ‘Berlin definition’ include 
acute onset and radiological evidence of 
bilateral infiltrates, which cannot be fully 
explained by cardiac failure or fluid over-
load and hypoxaemia.2 Based on the degree 
of hypoxaemia, three categories of ARDS 
(mild, moderate and severe) are determined 
by the current ‘Berlin definition’.2 About 
10% of ICU patients develop ARDS3 and 
despite optimal treatment, including prone 
positioning4 and extracorporeal membrane 
oxygenation (ECMO)5 for the most severe 
forms, recent hospital mortality estimates are 
as high as 46%.3 Above and beyond mortality, 
strengths and limitations of this study
 ► This is one of the few large acute respiratory dis-
tress syndrome (ARDS) survivor cohorts applying the 
current diagnostic criteria (‘Berlin definition’).
 ► This is the first large ARDS survivor cohort with 
explicit focus on health-related quality of life, 
characterisation of sociodemographic aspects and 
healthcare utilisation.
 ► The cohort is characterised by a wide range of dis-
ease-related and care-related information during 
intensive care unit (ICU) phase.
 ► It cannot be assumed that in the participating ICUs 
all patients with ARDS had the same probability to 
be included in the cohort (risk of selection bias).
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many ARDS survivors suffer from long-term persistent 
physical and mental morbidity.6 A systematic review with 
subsequent meta-analysis6 revealed lower pooled esti-
mated scores for all health-related quality of life (HRQoL) 
domains of the Medical Outcomes Study Short Form 
36-Item Health Survey in ARDS survivors compared with 
general population.7 Even 5 years after ICU discharge, 
ARDS survivors have decreased HRQoL and a reduced 
6 min walk distance compared with mean norm scores.8 
Among the mental disorders, increased prevalence 
rates are reported for depression, post-traumatic stress 
disorder (PTSD) and anxiety disorder in former patients 
with ARDS.9 10 Taken together, there is a growing body of 
evidence for decreased HRQoL and disability, but little 
is known about determinants of clinical relevance for 
HRQoL and return to work (RtW) in survivors of ARDS.11 
Furthermore, none of the large ARDS cohorts provide 
sufficient information on sociodemographic characteris-
tics of patients with ARDS and ARDS survivors.12 Against 
this background, an ARDS survivor cohort that allows 
investigation into the influences of hospital quality of 
care (QoC) and subsequent healthcare utilisation (HCU) 
on prolonged mental and physical morbidity, HRQoL 
and RtW is highly desirable.
Cohort desCrIPtIon
A sample of ARDS survivors in German ICUs has 
been selected within the scope of the DACAPO study 
(‘DACAPO: Surviving ARDS: the influence of quAlity 
of Care and individual Patient characteristics on quality 
Of life’ funded by German Federal Ministry of Educa-
tion and Research). The main objective of this study 
is to investigate the influence of QoC on HRQoL and 
RtW. With respect to the association between QoC and 
HRQoL/RtW, further hypotheses regarding moder-
ating effects of sex, socioeconomic status, social support 
and psychopathological symptoms should be tested. 
A detailed protocol of the study has been published 
previously.13
By conducting additional follow-ups every 12 months 
after discharge from ICU, this initial sample will be trans-
formed into the DACAPO (survivor) cohort. In particular, 
the DACAPO cohort will be set up to facilitate research in 
HCU and long-term psychiatric morbidity among ARDS 
survivors and to analyse long-term effects of QoC and 
HCU on HRQoL.
Between September 2014 and May 2016, 61 ICUs all 
over Germany included eligible patients with ARDS in 
the DACAPO ICU sample. Efforts were made to ensure 
that not only hospitals/ICUs specialised in the treatment 
of patients with ARDS (members of the ARDS Network 
Germany) participate, by reaching out to smaller urban 
or suburban hospitals. All participating clinics declared 
their willingness to include all eligible patients in the 
cohort during the period of recruitment. Written 
informed consent had to be provided by the patient. In 
patients who were cognitive incapable informed consent 
of patients’ caregivers or legal guardians needed to be 
obtained.
Eligible patients had to meet following criteria for 
inclusion in the DACAPO ICU sample:
 ► ARDS is diagnosed in one of the participating ICUs 
or a referring hospital according to the ‘Berlin 
definition’.
 ► Patient is older than 18 years at ARDS diagnosis.
In order to ensure maximal external validity of the 
DACAPO ICU sample, no further inclusion criteria and 
no exclusion criteria were applied.
The actual DACAPO cohort consists of the survivors of 
the DACAPO ICU sample (patients who were discharged 
alive from the ICU).
Measurements
During ICU treatment, a wide variety of sociodemo-
graphic, disease-related and care-related characteristics 
were recorded. Data acquisition was performed by means 
of web-based electronic case report forms (eCRFs). For 
this purpose, study nurses and physicians of every partic-
ipating hospital were trained with regard to the detailed 
specification of the data that should be collected and the 
operation of the eCRFs.
Along with two short-term follow-up assessments (3 
months and 6 months after ICU discharge), a yearly 
follow-up assessment is in progress.
Each follow-up consists of a paper–pencil questionnaire 
that is sent by post to the participant’s home address. In 
order to minimise drop-out rates, we routinely mail a 
reminder letter and place a reminder phone call asking 
participants to complete and sent back the question-
naire. If there is no response to the reminder letters and 
reminder calls, we get in touch with the local resident 
registration office to receive information about whether 
the participant has died (mortality follow-up) or moved 
to another address.
Exposure
QoC is assessed in all participating ICUs. In cases where 
ARDS has been diagnosed in a referring hospital, QoC 
has been determined for the referring ICU as well. For 
this purpose, we apply the indicators of the quality assur-
ance programme for intensive care implemented by the 
Deutsche Interdisziplinäre Vereinigung für Intensiv- und 
Notfallmedizin (German Interdisciplinary Association for 
Intensive and Emergency Medicine).14 These indicators 
are situated at the level of process and structural quality. 
In addition to this generic quality of intensive care indi-
cator set, several ARDS specific variables have been incor-
porated. All indicators will be assessed by questionnaire at 
the institutional level.
If applicable, QoC was assessed on individual patient 
level for the interhospital transport between the referring 
hospitals and the participating ICUs. Particular attention 
was paid to indicators regarding process quality (medical 
equipment of the vehicle and medical qualifications of 
personnel).
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An important issue to be investigated based on the data 
of the DACAPO cohort is the long-term effects of HCU 
on HRQoL and RtW. Therefore, the follow-up question-
naires (starting from the 6-month follow-up) include 
questions regarding utilisation of ambulatory, inpatient 
and rehabilitative healthcare services.
ICu baseline: moderator variables and covariates
With regard to a valid assessment of morbidity and 
disease severity, several scores for morbidity and disease 
severity (Simplified Acute Physiology Score (SAPS) 
II,15 SAPS III,16 Sequential Organ Failure Assess-
ment (SOFA) score17 have been recorded on item level 
for every patient at the time of (1) admission, (2) diag-
nosis of ARDS, (3) 24 hours after diagnosis and (4) 
discharge from ICU. For the sociodemographic charac-
terisation age, gender, marital status, educational and 
professional level, living condition and socioeconomic 
status have been captured based on the information 
of the relatives/legal guardians. In addition, medical/
supportive treatment (ECMO, tracheotomy, nitric 
oxide (NO) inhalation, prone positioning and neuro-
muscular blockers) and adverse events (hypoglycaemia, 
hypoxia, accidental extubation and reintubation) have 
been assessed on individual patient level. In particular, 
most of the variables recorded in the phase of ICU treat-
ment are intended to be covariates for the adjustment of 
disease severity, comorbidity and socioeconomic status 
in the final statistical model determining the influence 
of QoC on HRQoL and RtW. In addition, these medical 
baseline data (possibly combined with the exposure 
and/or outcome measurements) can serve as database 
for future clinical epidemiology research.
Follow-up: outcomes
The primary outcome is assessed by the Short Form-12 
self-report questionnaire (SF-12), which has two scales 
(one for physical health and one for mental health).18
The secondary outcome RtW is determined by several 
items relating to date and extent of RtW.
Follow-up: moderator variables and covariates
Social support (emotional support, instrumental support 
and social integration) is assessed by using the F-SozU 
K-14.19 Symptoms of depression, panic disorder and 
alcohol abuse are assessed by the corresponding modules 
of the validated German version20 21 of the Patient Health 
Questionnaire (PHQ).22 With regard to the ICU stay, 
three categories of PTSD symptoms (emotional numbing, 
intrusion and hyperarousal) are determined by the 
screening tool Post-Traumatic Stress Syndrome 14-Ques-
tions Inventory (PTSS-14).23 Furthermore, the MacAr-
thur Scale is used to determine subjective social status. 
This approach includes a rating of the perceived social 
position in the community on the scales of a ladder.24
ChArACterIstICs oF study PArtICIPAnts
Overall, 1900 patients with ARDS were enrolled in the elec-
tronic data capture system. Informed consent was obtained 
by 1225 of the patients or their legal guardians. The 876 
ARDS survivors at the time of ICU discharge form the actual 
DACAPO cohort. A diagram of the patient flow is provided 
in figure 1. Descriptive statistics of sociodemographic and 
medical characteristics at the time of admission for the entire 
DACAPO ICU sample and for the DACAPO cohort (ICU 
survivors) are presented in table 1. Small to moderate numbers 
of missing data in the medical variables are attributable to the 
Figure 1 Patient flow of the DACAPO cohort. ICU, intensive care unit.
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fact that many of the clinical and care-related characteristics 
are routinely recorded in the ICU setting.
Findings to date
The distribution of sex and age in our cohort is in perfect 
accordance with other large ARDS cohorts, which reveal 
that in particular older men are at higher risk for ARDS. 
Furthermore, the high prevalence of pulmonary diseases 
including pneumonia as most important risk factor of 
ARDS is in line with the scientific literature in this area.12
Taking a closer look at critical events (hypoxia, hypo-
glycaemia, unintended extubation and reintubation) 
and supportive measures (tracheotomy, NO inhalation, 
ECMO, prone positioning and neuromuscular blockers) 
during ICU treatment, in particular the application of 
ECMO and prone positioning, were frequent, whereas 
critical events like hypoglycaemia also had a high prev-
alence.12 These findings point out the potential for 
improvement in intensive care routines. However, the 
results reveal a comprehensive implementation of 
evidence-based measures like prone positioning25 26 and 
neuromuscular blockers.27
Against the background of changing diagnostic 
ARDS criteria, further comparisons of medical charac-
teristics and outcomes between studies/cohorts should 
Table 1 Selected baseline sociodemographic and medical characteristics of the DACAPO ICU sample and of the ICU 
survivors (initial DACAPO cohort)
DACAPO ICU sample DACAPO cohort
Sociodemographic characteristics
  Sex (N) 1225 876
   Female, n (%) 386 (31.5) 278 (31.7)
  Age (N) 1225 876 
   Years, Md (IQR) 58.0 (47.0–68.0) 56.0 (44.0–66.0)
  Educational level* (N) 1185 849
   No school leaving certificate, n (%) 23 (1.9) 20 (2.4)
   Not yet a school leaving certificate, n (%) 10 (0.8) 9 (1.1)
   Schooling <10 years
   Secondary school leaving certificate, n (%) 416 (35.1) 297 (35.0)
   Schooling=10 years
   Intermediate school leaving certificate, n (%) 331 (27.9) 233 (27.4)
   Schooling >10 years
   University entrance level, n (%) 188 (15.9) 140 (16.5)
   Unknown or other n (%) 217 (17.7) 150 (17.7)
Medical characteristics
  SAPS-II†§ score (N) 1102 789
   Md (IQR) 40.0 (32.0–49.0) 38.0 (31.0–47.0)
  SOFA‡ score (N) 909 654
   Md (IQR) 9.0 (6.0–12.0) 8.0 (6.0–11.0)
  Cause of ARDS (N) 1205 859
   Pulmonary, n (%) 977 (81.1) 698 (81.3)
   Extrapulmonary, n (%) 190 (15.5) 134 (15.6)
   Not specified, n (%) 38 (3.1) 27 (3.1)
  Severity of ARDS§ (N) 1211 862
   Mild, n (%) 144 (11.9) 102 (11.8)
   Moderate, n (%) 547 (45.2) 406 (47.1)
   Severe, n (%) 520 (42.4) 354 (41.1)
Note: numbers do not add up to n=1225 for all patients or to n=876 for survivors due to missing values. 
*Data were provided by patients’ caregivers/legal guardians.
†As assessed at admission at the DACAPO ICU.
‡As assessed at time of ARDS diagnosis.
§SAPS-II score was calculated without the Glasgow Coma Scale.
ARDS, acute respiratory distress syndrome; ICU, intensive care unit; Md, median; SAPS, Simplified Acute Physiology Score; SOFA, 
Sequential Organ Failure Assessment.
 o
n
 9 M
ay 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019342 on 4 April 2018. Downloaded from 
5Dodoo-Schittko F, et al. BMJ Open 2018;8:e019342. doi:10.1136/bmjopen-2017-019342
Open Access
be drawn with caution. The Large observational study to 
UNderstand the Global impact of Severe Acute respirar-
tory FailurE (LUNG SAFE)3 provides currently the only 
reliable sample of patients with ARDS corresponding to 
the current criteria of the ‘Berlin definition’. The distri-
bution of ARDS severity revealed by the LUNG SAFE 
sample differs from our findings. While LUNG SAFE 
reports the lowest proportion of persons with severe 
ARDS, the baseline data of our investigation indicate a 
much higher proportion of patients with severe ARDS 
and a lower proportion of patients with mild ARDS, but 
nevertheless the overall ICU mortality rate (28.4%) is 
lower in our DACAPO ICU sample.3 12
strengths and limitations
One of the strengths of the DACAPO cohort is the char-
acterisation of ARDS survivors with a particular focus on 
sociodemographic conditions (education, socioeconomic 
status, marital status and so on). With regard to infor-
mation bias, only validated instruments with satisfying 
psychometric properties are applied for psychometric 
constructs. A further strength is the broad spectrum of 
hospitals respectively ICUs that participated in patient 
recruitment. We were successful in involving university 
hospitals providing up-to-date apparatus and optimal 
personnel resources as well as smaller urban and suburban 
hospitals. This approach should reduce selection bias and 
ensure external validity. Additionally, in order to draw a 
representative sample/cohort of the general population 
of ARDS survivors, no exclusion criteria were applied.
However, the sample of the participating ICUs was 
drawn following a convenience sampling method, and the 
distribution of ARDS severity in the DACAPO ICU sample 
is not in accordance with the only large study3 applying 
the current Berlin definition of ARDS.2 The latter point 
tends to indicate that, although physicians of the partici-
pating ICUs have been trained in applying the diagnostic 
ARDS criteria of the Berlin definition, the mild form of 
ARDS is frequently overlooked in intensive care routine. 
This, in turn, would lead to a loss of representativeness of 
the DACAPO cohort and points out the need to screen all 
patients for eligibility in order to ensure representative-
ness, in particular if empirical and consensus-based and, 
therefore, non-salient syndromes like ARDS are investi-
gated. Against this background, a strict implementation 
Figure 2 Main objectives and add-on projects using data of the DACAPO ICU sample/DACAPO cohort. (I) Main objective 
of the DACAPO study; (II) main objective of the DACAPO cohort; (III) genetic add-on project; and (IV) add-on projects with 
clinical background. aAn additional DNA analysis for the participants of the DACAPO cohort is intended. bFor some of the 
research questions, a retrospective collection of medical data is required. cAn additional follow-up with specific measurement 
instruments is intended for some research questions. ARDS, acute respiratory distress syndrome; HRQoL, health-related quality 
of life; HCU, healthcare utilisation; ICU, intensive care unit; PTSD, post-traumatic stress disorder; QoC, quality of care; RtW, 
return to work.
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of an entity apart from the daily clinical routines that 
conducts the screening process every day would have 
been expedient. Because of the considerable number 
of participating ICUs, this approach was not feasible in 
practice.
Nevertheless, the DACAPO cohort is one of the largest 
cohorts of ARDS survivors described in literature and 
should be suitable for analytical issues related to associa-
tions between QoC, disease-related or care-related patient 
characteristics and physical, mental or social difficulties at 
the follow-up evaluations. At the same time, the DACAPO 
cohort enables taking into consideration important 
aspects of the individual sociodemographic conditions.
Collaborations
On the basis of a regulation given by the principal investi-
gators of the study, every participating ICU that included 
at least one patient is encouraged to propose research 
questions that could be examined using the data provided 
by the DACAPO ICU sample, the DACAPO cohort and 
the data of the assessment of QoC. Figure 2 provides an 
overview of the main objective of the DACAPO study and 
envisaged projects going beyond.
The aim of a genetic add-on project is to investigate 
in ARDS survivors whether (1) there is an association 
between the NF-κB1 (−94 ins/del ATTG) promoter poly-
morphism and HRQoL and/or RtW and whether (2) the 
C957T polymorphism of dopamine D2 receptor gene and 
a single nucleotide polymorphism in SLC18A2 (rs363276) 
are associated with increased incidence of PTSD. There-
fore, a DNA analysis of the DACAPO cohort participants 
using oral mucosa swabs is intended.
Furthermore, several add-on projects concerned with 
clinical topics of high relevance are currently under 
preparation. For some of these projects, the retrospective 
collection of additional medical ICU variables on indi-
vidual patient level is required. For other research ques-
tions, an adapted follow-up questionnaire with additional 
measurement instruments (dysphagia, chronic pain and 
so on) has to be conducted (see figure 2). For details 
regarding the availability of data for potential new collab-
orators, see the data sharing section.
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